Roth Capital Starts Æterna Zentaris (AEZS) at Buy
Tweet Send to a FriendGet Alerts AEZS Hot Sheet
Price: $2.02 -0.49%
Rating Summary:
3 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
3 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade AEZS Now!
Roth Capital initiates coverage on Æterna Zentaris (NASDAQ: AEZS) with a Buy. PT $1.75.
For an analyst ratings summary and ratings history on Æterna Zentaris click here. For more ratings news on Æterna Zentaris click here.
Shares of Æterna Zentaris closed at $0.68 yesterday, with a 52 week range of $0.38-$2.17.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Æterna Zentaris click here. For more ratings news on Æterna Zentaris click here.
Shares of Æterna Zentaris closed at $0.68 yesterday, with a 52 week range of $0.38-$2.17.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Guggenheim Starts Biota Pharmaceuticals (BOTA) at Buy
- Topeka Capital Starts CEVA Inc. (CEVA) at Buy
- Aeterna Zentaris: Posters to be Presented on Phase 1 and Phase 2 Trials with AEZS-108 in Prostate and Breast Cancer at Upcoming ASCO Meeting
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Roth Capital
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
